Crohn's Disease and Colitis Trial, Recruiting NCT06756100 Sponsor: Pontificia Universidad Catolica de Chile Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, Recruiting

NCT06756100
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are an adult who has been experiencing gut-related symptoms — such as diarrhea, rectal bleeding, stomach pain, a feeling of needing to strain when using the toilet, or an urgent need to use the toilet — for at least 3 weeks.

Who may not be able to join:

  • You have been diagnosed with a confirmed infection in your digestive system (such as a bacterial or viral gut infection).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Cristian Hernández-Rocha, MD, Pontificia Universidad Catolica of chile

Phone: 56-22-3543822

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Pontificia Universidad Catolica de Chile
Registry
ClinicalTrials.gov
Start date
7 July 2023
Est. completion
1 April 2027

Where this trial is recruiting

🇨🇱 Chile

Primary endpoints

Compare gut microbiome composition and function from different sample types among participants with gastrointestinal symptoms with and without confirmed IBD by colonoscopy and biopsy; In patients with confirmed IBD, researchers will identify whether there are differences in gut microbiome composition and function between patients who need therapy escalation (progressors) within the first 12 months after diagnosis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov